AACR Annual Meeting 2015

By 10 avril 2015Event

NETRIS Pharma will attend the AACR Annual Meeting 2015 in Philadelphia, US (April 18th-22nd). For this occasion, NETRIS Pharma will present recent data regarding its first-in-class humanized anti-Netrin-1 antibody NP137, currently in late preclinical development phase. A First-In-Human trial is expected for late 2015/early 2016 in collaboration with EORTC. This work is supported by the FP7 Hermione-2-Man grant from European Union.